£2.4M
The funding round was led by Mercia EIS Funds alongside several institutional backers.
CD
ClinSpec Dx
ClinSpec Dx develops blood test technology for the early detection of cancer.
Scotland, UK
£2.4MTotal raised
ClinSpec Dx is a Scottish early cancer detection company that originated as a spinout from the University of Strathclyde.